← Leaderboards
John Mascola
National Institute Of Allergy And Infectious Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Allergy And Infectious Diseases
Same institution · by research overlap
Others in their field
Top investigators on “Hiv-1”
- Barton F Haynes · Duke University$476,288,740
- Lawrence Corey · Fred Hutchinson Cancer Center$445,419,385
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$294,186,693
- Constance Ann Benson · University Of California, San Diego$272,046,180
- Peter B. Gilbert · Fred Hutchinson Cancer Center$173,010,936
- Dan H. Barouch · Fred Hutchinson Cancer Center$166,542,502
Research focus
Hiv-1Neutralizing AntibodyAntibodiesVaccinesVirusAntigensBaseImmune ResponseCellsAnimalsInfectionSerumMonoclonal AntibodiesDesignProteinsViralHiv InfectionsVaccine CandidateNonhuman PrimateRecombinantsIn VivoGlycoproteinsStructureEvaluation
Grant awards (95)
Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases$3,934,150
ZIC · FY2021 · AI · contact PI
Pre-clinical Vaccine Development for Respiratory Viruses$2,543,625
ZIC · FY2021 · AI · contact PI
HIV/AIDS Vaccine and Antibody Development$2,396,730
ZIC · FY2021 · AI · contact PI
Quantitative Immunological Assays to Assess HIV Antibodies and Vaccines$867,443
ZIC · FY2021 · AI · contact PI
HIV Neutralizing Antibodies: Isolation, characterization, and interaction with viral variants$867,443
ZIA · FY2021 · AI · contact PI
Pre-clinical Vaccine and Antibody Development for Coronavirus Disease 2019 (COVID-19)$393,065
ZIA · FY2021 · AI · contact PI
Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases$4,122,850
ZIC · FY2020 · AI · contact PI
Pre-clinical Vaccine Development for Respiratory Viruses$2,748,001
ZIC · FY2020 · AI · contact PI
HIV/AIDS Vaccine and Antibody Development$1,789,546
ZIC · FY2020 · AI · contact PI
HIV Neutralizing Antibodies: Isolation, characterization, and interaction with viral variants$665,130
ZIA · FY2020 · AI · contact PI
Quantitative Immunological Assays to Assess HIV Antibodies and Vaccines$665,130
ZIC · FY2020 · AI · contact PI
Pre-clinical Vaccine and Antibody Development for Coronavirus Disease 2019 (COVID-19)$253,477
ZIA · FY2020 · AI · contact PI
Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases$3,639,529
ZIC · FY2019 · AI · contact PI
HIV/AIDS Vaccine and Antibody Development$3,413,428
ZIC · FY2019 · AI · contact PI
Quantitative Immunological Assays to Assess HIV Antibodies and Vaccines$552,628
ZIC · FY2019 · AI · contact PI
Isolation and Deep Sequencing of Monoclonal Antibodies Against HIV$206,006
ZIA · FY2019 · AI · contact PI
Measurement of HIV Neutralization Using Quantitative Assays$2,467,107
ZIA · FY2018 · AI · contact PI
Isolation and Deep Sequencing of Monoclonal Antibodies Against HIV$2,287,556
ZIA · FY2018 · AI · contact PI
Determination of the Neutralization Specificity in Broadly Neutralizing HIV Sera$2,167,856
ZIA · FY2018 · AI · contact PI
Preclinical Evaluation Of Neutralizing Antibodies Elicited by HIV-1 Immunogens$1,569,354
ZIA · FY2018 · AI · contact PI
Modifications to improve HIV neutralizing antibodies$1,569,354
ZIA · FY2018 · AI · contact PI
Non Human Primate Models of SIV and HIV Immune Protection$1,255,483
ZIA · FY2018 · AI · contact PI
HIV/AIDS Vaccine Development$1,255,483
ZIA · FY2018 · AI · contact PI
Mechanisms Of HIV-1 Induced Cell Death and Latency Formation in CD4+ Lymphocytes$104,624
ZIA · FY2018 · AI · contact PI
Measurement of HIV Neutralization Using Quantitative Assays$2,913,225
ZIA · FY2017 · AI · contact PI
Isolation and Deep Sequencing of Monoclonal Antibodies Against HIV$2,692,904
ZIA · FY2017 · AI · contact PI
Determination of the Neutralization Specificity in Broadly Neutralizing HIV Sera$2,582,744
ZIA · FY2017 · AI · contact PI
Preclinical Evaluation Of Neutralizing Antibodies Elicited by HIV-1 Immunogens$2,031,942
ZIA · FY2017 · AI · contact PI
Modifications to improve HIV neutralizing antibodies$2,031,941
ZIA · FY2017 · AI · contact PI
Non Human Primate Models of SIV and HIV Immune Protection$1,848,705
ZIA · FY2017 · AI · contact PI
HIV/AIDS Vaccine Development$1,848,705
ZIA · FY2017 · AI · contact PI
Mechanisms Of HIV-1 Induced Cell Death and Latency Formation in CD4+ Lymphocytes$1,176,839
ZIA · FY2017 · AI · contact PI
HIV/AIDS Vaccine Development$5,585,016
ZIA · FY2016 · AI · contact PI
Modifications to improve HIV neutralizing antibodies$2,006,000
ZIA · FY2016 · AI · contact PI
Determination of the Neutralization Specificity in Broadly Neutralizing HIV Sera$1,646,797
ZIA · FY2016 · AI · contact PI
Isolation and Deep Sequencing of Monoclonal Antiobodies Against HIV$646,797
ZIA · FY2016 · AI · contact PI
Preclinical Evaluation Of Neutralizing Antibodies Elicited by HIV-1 Immunogens$646,797
ZIA · FY2016 · AI · contact PI
Non Human Primate Models of SIV and HIV Immune Protection$536,803
ZIA · FY2016 · AI · contact PI
Mechanisms Of HIV-1 Induced Cell Death and Latency Formation in CD4+ Lymphocytes$526,670
ZIA · FY2016 · AI · contact PI
Measurement of HIV Neutralization Using Quantitative Assays$524,707
ZIA · FY2016 · AI · contact PI
HIV/AIDS Vaccine Development$6,479,016
ZIA · FY2015 · AI · contact PI
Modifications to improve HIV neutralizing antibodies$1,800,000
ZIA · FY2015 · AI · contact PI
Determination of the Neutralization Specificity in Broadly Neutralizing HIV Sera$440,797
ZIA · FY2015 · AI · contact PI
Isolation and Deep Sequencing of Monoclonal Antiobodies Against HIV$440,797
ZIA · FY2015 · AI · contact PI
Preclinical Evaluation Of Neutralizing Antibodies Elicited by HIV-1 Immunogens$440,797
ZIA · FY2015 · AI · contact PI
Non Human Primate Models of SIV and HIV Immune Protection$330,803
ZIA · FY2015 · AI · contact PI
Measurement of HIV Neutralization Using Quantitative Assays$318,707
ZIA · FY2015 · AI · contact PI
Mechanisms Of HIV-1 Induced Cell Death and Latency Formation in CD4+ Lymphocytes$220,670
ZIA · FY2015 · AI · contact PI
HIV/AIDS Vaccine Development$6,479,016
ZIA · FY2014 · AI · contact PI
Modifications to improve HIV neutralizing antibodies$1,800,000
ZIA · FY2014 · AI · contact PI
Recombinant Adenovirus Vector Vaccine Studies$1,172,046
ZIA · FY2014 · AI · contact PI
AAV vectored vaccines$549,483
ZIA · FY2014 · AI · contact PI
Determination of the Neutralization Specificity in Broadly Neutralizing HIV Sera$440,797
ZIA · FY2014 · AI · contact PI
Isolation and Deep Sequencing of Monoclonal Antiobodies Against HIV$440,797
ZIA · FY2014 · AI · contact PI
Preclinical Evaluation Of Neutralizing Antibodies Elicited by HIV-1 Immunogens$440,797
ZIA · FY2014 · AI · contact PI
Non Human Primate Models of SIV and HIV Immune Protection$330,803
ZIA · FY2014 · AI · contact PI
Measurement of HIV Neutralization Using Quantitative Assays$318,707
ZIA · FY2014 · AI · contact PI
Mechanisms Of HIV-1 Entry and Transfer to CD4+ T cells$220,670
ZIA · FY2014 · AI · contact PI
HIV/AIDS Vaccine Development$6,479,015
ZIA · FY2013 · AI · contact PI
Modifications to improve HIV neutralizing antibodies$1,800,000
ZIA · FY2013 · AI · contact PI
Recombinant Adenovirus Vector Vaccine Studies$1,495,001
ZIA · FY2013 · AI · contact PI
AAV vectored vaccines$549,483
ZIA · FY2013 · AI · contact PI
Isolation and Deep Sequencing of Monoclonal Antiobodies Against HIV$440,797
ZIA · FY2013 · AI · contact PI
Preclinical Evaluation Of Neutralizing Antibodies Elicited by HIV-1 Immunogens$440,797
ZIA · FY2013 · AI · contact PI
Determination of the Neutralization Specificity in Broadly Neutralizing HIV Sera$440,797
ZIA · FY2013 · AI · contact PI
Non-human Primate Immunogenicity Studies of HIV-1 immunogens$330,804
ZIA · FY2013 · AI · contact PI
Non Human Primate Models of SIV and HIV Immune Protection$330,803
ZIA · FY2013 · AI · contact PI
Mechanisms Of HIV-1 Entry and Transfer to CD4+ T cells$220,670
ZIA · FY2013 · AI · contact PI
Measurement of HIV Neutralization Using Quantitative Assays$220,536
ZIA · FY2013 · AI · contact PI
Preclinical Evaluation Of Neutralizing Antibodies Elicited by HIV-1 Immunogens$440,797
ZIA · FY2012 · AI · contact PI
Determination of the Neutralization Specificity in Broadly Neutralizing HIV Sera$440,797
ZIA · FY2012 · AI · contact PI
Isolation and Deep Sequencing of Monoclonal Antiobodies Against HIV$440,797
ZIA · FY2012 · AI · contact PI
Non-human Primate Immunogenicity Studies of HIV-1 immunogens$330,804
ZIA · FY2012 · AI · contact PI
Non Human Primate Models of SIV and HIV Immune Protection$330,803
ZIA · FY2012 · AI · contact PI
Measurement of HIV Neutralization Using Quantitative Assays$220,536
ZIA · FY2012 · AI · contact PI
Determination of the Neutralization Specificity in Broadly Neutralizing HIV Sera$440,797
ZIA · FY2011 · AI · contact PI
Isolation and Deep Sequencing of Monoclonal Antiobodies Against HIV$440,797
ZIA · FY2011 · AI · contact PI
Preclinical Evaluation Of Neutralizing Antibodies Elicited by HIV-1 Immunogens$440,797
ZIA · FY2011 · AI · contact PI
Non-human Primate Immunogenicity Studies of HIV-1 immunogens$330,804
ZIA · FY2011 · AI · contact PI
Non Human Primate Models of SIV and HIV Immune Protection$330,801
ZIA · FY2011 · AI · contact PI
Measurement of HIV Neutralization Using Quantitative Assays$220,536
ZIA · FY2011 · AI · contact PI
Determination of the Neutralization Specificity in Broadly Neutralizing HIV Sera$443,957
ZIA · FY2010 · AI · contact PI
Preclinical Evaluation Of Neutralizing Antibodies Elicited by HIV-1 Immunogens$443,957
ZIA · FY2010 · AI · contact PI
Isolation of Monoclonal Antiobodies Against HIV$443,957
ZIA · FY2010 · AI · contact PI
Non-human Primate Immunogenicity Studies of HIV-1 immunogens$332,967
ZIA · FY2010 · AI · contact PI
Non Human Primate Models of SIV and HIV Immune Protection$332,967
ZIA · FY2010 · AI · contact PI
Measurement of HIV Neutralization Using Quantitative Assays$221,978
ZIA · FY2010 · AI · contact PI
Non Human Primate Models of SIV and HIV Immune Protection$211,697
ZIA · FY2009 · AI · contact PI
Preclinical Evaluation Of Neutralizing Antibodies Elicited by HIV-1 Immunogens$211,697
ZIA · FY2009 · AI · contact PI
Measurement of HIV Neutralization Using Quantitative Assays$211,697
ZIA · FY2009 · AI · contact PI
Non-human Primate Immunogenicity Studies of HIV-1 immunogens$211,697
ZIA · FY2009 · AI · contact PI
Evaluation of Antibody Specificities in Broadly Neutralizing HIV Sera$211,697
ZIA · FY2009 · AI · contact PI
Isolation of Monoclonal Antiobodies Against HIV$211,696
ZIA · FY2009 · AI · contact PI
Evaluation of Antibody Specificities in Broadly Neutralizing HIV Sera$305,129
Z01 · FY2008 · AI · contact PI
Isolation of Monoclonal Antiobodies Against HIV$305,129
Z01 · FY2008 · AI · contact PI